Minutes, May 25, 1926

May 25, 1926. On Wednesday, May 19th, 1926, at 10:30 s.m., I attended a conference of certain officers and directors of the United States Radium Corporation held at the office of the Company, 30 Church Street, New York City, to meet at his request Dr. Joseph P. Knef of Newark, New Jersey. At this conference I as.w Dr. Knef for the first time. Dr. Knef stated that he had asked for this conference as he was look- ing for justice, that he had done nuch research work in connection with the 80- called radium necrosis ceses, had spent nuch time in treating patients who had been employed by the United States Radium Corporation and that he had not been sufficiently paid for his services and that he must be paid by some one. He stated that he knew of many more cases which were coming up, which cases might result in further suits against the Company. If we would pay hin now $10,000 he would work with us but if we would not pay hin $10,000 he would have to work against us and would cause hie patients to bring suit against the Corporation in order that they might obtain funds out of which he could be paid. He stated that not only could he influence patiente in the natter of bringing suit but also as a witness he could testify either way - that is, that the trouble was caused by radium it was not causeed by radium personing secress some other cause such as pyrrchea. He exhibited a number of photographs and ex-ray films and explained same in some detail. He kept constantly repeating that he must be compensated for hie services. He auggested that he be given a list of the girls who had previously worked for the Corporation in order that he could lo- cate then and try to influence them to take his treatment, which treatment he had worked out through his research work on the subject of radium necrosis. He wanted to know if we were going to play ball with him. He stated that he knew more about the subject of radium necrosi 8 than anyone else and that he could testify in a way that would result in judgments against the Company.